Where Structured Products Really Belong in a Portfolio

05 May 2026

|

5 minute read

Structured products are usually sold one at a time.
You’re shown a glossy payoff chart, an impressive coupon, and a soothing word like “protection”. You’re rarely shown the more useful question: “Where does this actually sit in the portfolio you already have?”

This article is about that question: how a sensible investor decides whether a structured product has any business being there at all. And if it does, the next step is in which corner of the portfolio it lives.

Before you even look at a term sheet, you should be able to say what job you’re hiring a product to do.

Three honest “jobs”:

  • “I want some upside, but I’d like a floor at a certain date.”
  • “I’d like more income than cash gives me, and I accept it might switch off when markets sulk.”
  • “I have a view: I think markets will be roughly flat / gently up, not boom or bust.”

Now the boring but crucial step: could a simple mix of funds and bonds do this already?

  • Floor job: a ladder of decent bonds plus a basic equity fund.
  • Income job: a bond fund or equity income fund.
  • View job: own the index and put up with the usual ups and downs.

A structured product only pulls its weight if it gives you something extra you actually care about. For example, “I want that floor on exactly this date, in one instrument, and I’m willing to pay for it.”

If your real reason is “the coupon is bigger than my savings account and the graph looks tidy”, that’s not a job. That’s just boredom with better branding.

Once you know the job, you decide which bucket it belongs in.

A simple rule:
“If, in the worst case, I can lose equity‑type money, this sits in the equity bucket – however bond‑like the coupon looks.”

In practice:

  • Equity bucket – Products with autocalls, yield notes, reverse convertibles – anything where a nasty market can hand you a proper capital loss. These live next to shares, not next to gilts.
  • Defensive / bond bucket – Capital‑protected notes from solid issuers, held to maturity, can sometimes replace part of the bond slice. Just be clear that “protected” usually means “at maturity, in nominal pounds, if the bank is still standing.
  • Funmoney / satellite bucket – Flashy themes, single‑stock trades with a bow on. This is the “if it goes wrong, I’ll be annoyed but not ruined” corner.

The mis‑selling disasters tend to start when something that should live in “equity” is placed in “safe”. The statement heading may say “low risk”; the payoff doesn’t read it.

A structured product at 2% of your portfolio is a tool. The same product at 30% is a personality trait.

You don’t need a PhD‑grade model. You just need a few guardrails:

  • Keep all structured products together to a modest slice – say up to around 10% of total assets for most people. Go above that only if you have a very clear reason.
  • Keep any single note small – a couple of percent of your net worth is plenty. Enough to matter, not enough to dominate.
  • Watch issuer concentration. Ten “different” notes from the same bank is still one big unsecured loan to that bank, just with different shaped payoffs stapled on.

If you wouldn’t put 30% of your wealth in one single share from one company, don’t do the same via that company’s note programme. Same risk, nicer brochure.

Most structured products are a deal between you and a bank that says, roughly: “You leave the money with us. We promise a certain pattern of payoffs. Don’t ask for it back early unless you enjoy disappointing numbers.”

So, at portfolio level, the key question is painfully simple:
“Can I genuinely leave this money alone until the stated maturity date?”

If the answer is “maybe not”, it doesn’t matter how clever the payoff is. You’re relying on a secondary market that is often:

  • one dealer,
  • one indicative quote,
  • and one wide spread away from ruining your evening.

Match the note to money you won’t need for a while. If you might need it for school fees, a house move, or a business wobble, it belongs in cash and plain bonds. Not in a product that only fully makes sense in year five.

Put it all together and the bar becomes clear. It’s not a complicated bar, but it is a bit unforgiving.

A structured product can deserve a seat when:

  • You can finish this sentence in plain English: – “I’m using this to do X in my portfolio, and I accept Y and Z in return.” (For example: “I’m using this to get a floor on money for a known date, and I accept limited upside and issuer risk.”)
  • You’ve put it in the right bucket – risky things live with risky things – and sized it so that a bad outcome is painful, not fatal.
  • The job genuinely isn’t done as well by a simpler mix of funds and bonds you already understand.

If you can’t explain it without waving the brochure, if you’re mainly there for the coupon, or if you’re stuffing gaps in the portfolio with products because they look “sophisticated”, the portfolio isn’t getting any smarter. It’s just getting more complicated to regret later.

Structured products aren’t magic beans and they’re not poison. They’re just bond‑plus‑options trades in fancy wrapping, with some extra conditions bolted on.

Used sparingly, in the right corner of a portfolio, by someone who can say in one sentence why the product is there, they can be perfectly decent tools. Used as a short‑cut to “feels safe, pays more than cash”, they’re an expensive way to learn the difference between a promise on a chart and a contract in real life.

If you know which job you’re hiring it for, which bit of your portfolio it’s moving into, and how annoyed you’ll be if it does the worst‑case scenario, you’re already doing more thinking than most of the brochure. At that point, the question isn’t “are structured products good or bad?”, it’s simply whether this particular deal is worth the space you’re giving it.

Subscribe for Exclusive Content, Newsletters and Early Access

Stay updated with the latest insights and articles delivered to your inbox weekly.

Stay Informed with Our Updates

Subscribe to our newsletter for the latest insights and expert advice
on funding structures.